Investors

Introduction

Arcturus Therapeutics Ltd. is a preclinical-stage biopharmaceutical company primarily focused on the discovery, development and commercialization of RNA medicines using proprietary lipid-mediated delivery system (LUNAR™) and UNA Oligomer chemistry technologies.

The Investor Relations section is designed to provide easy access to company information.

NASDAQ: ARCT

$ 9.10

4:00 PM | Nov 22, 2017
+$0.23
(2.59%)

Day High: 9.47
Day Low:  8.81
Volume:    33,825
Delayed ~20 min., by eSignal.